<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Risk stratification and management after an exposure to mpox (monkeypox)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Risk stratification and management after an exposure to mpox (monkeypox)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Risk stratification and management after an exposure to mpox (monkeypox)</div><div class="cntnt"><table cellspacing="0"><colgroup width="15%"></colgroup><colgroup span="3" width="35%"></colgroup><colgroup width="15%"></colgroup> <tbody> <tr> <td class="subtitle1">Exposure category</td> <td class="subtitle1">Community</td> <td class="subtitle1">Health care setting</td> <td class="subtitle1">Management*</td> </tr> <tr> <td><strong>Higher (known exposure)</strong></td> <td> <ul> <li>Any sexual or intimate contact involving mucous membranes (eg, kissing, oral-genital, oral-anal, vaginal, or anal sex [insertive or receptive]) with a source patient who has mpox</li> </ul> <p class="extra_spacing"><strong>or</strong></p> <ul> <li>Contact between an exposed individual's broken skin or mucous membranes with either: <ul> <li>The skin lesions or bodily fluids from a source patient with mpox</li> <li>Materials (eg, linens, clothing, objects, sex toys) that have contacted the skin lesions or bodily fluids of a source patient with mpox without having been disinfected or laundered<sup>¶</sup><sup>Δ</sup></li> </ul> </li> </ul> </td> <td> <ul> <li>Unprotected contact between an exposed HCP's broken skin or mucous membranes and either: <ul> <li>The skin lesions or bodily fluids from a patient with mpox (eg, inadvertent splashes of patient saliva to the eyes or mouth of HCP, needlesticks)</li> <li>Soiled materials (eg, linens, clothing)</li> </ul> </li> </ul> <p class="extra_spacing"><strong>or</strong></p> <ul> <li>Being inside the patient's room or within 6 feet of a patient with mpox without wearing a NIOSH-approved particulate respirator with N95 filters or higher and eye protection during either: <ul> <li>Medical procedures that may create aerosols from oral secretions (eg, tracheal intubation and extubation, tracheotomy, bronchoscopy, noninvasive ventilation)</li> <li>Activities that may resuspend dried exudates (eg, shaking of soiled linens)</li> </ul> </li> </ul> </td> <td> <p>Post-exposure vaccination warranted<sup>◊</sup></p> Monitor for 21 days</td> </tr> <tr class="highlight_gray_text"> <td><strong>Higher (presumed exposure)</strong></td> <td> <ul> <li>Gay, bisexual, or other men who have sex with men, or transgender and gender diverse people who have sex with men, who have had any of the following within the past 14 days: <ul> <li>Sex with multiple partners (or group sex)</li> <li>Sex at a commercial sex venue</li> <li>Sex in association with an event, venue, or defined geographic area where monkeypox virus transmission is occurring</li> </ul> </li> </ul> </td> <td> <ul> <li>N/A</li> </ul> </td> <td> <p>Post-exposure vaccination<sup>◊</sup><sup>§</sup></p> Monitor for 21 days</td> </tr> <tr> <td><strong>Intermediate</strong></td> <td> <ul> <li>Being within 6 feet for 3 hours or more (cumulative) of an unmasked person with mpox without wearing a surgical mask or respirator</li> </ul> <p class="extra_spacing"><strong>or</strong></p> <ul> <li>Contact between an exposed individual's intact skin with either: <ul> <li>The skin lesions or bodily fluids from a source patient with mpox</li> <li>Materials (eg, linens, clothing, objects, sex toys) that have contacted the skin lesions or bodily fluids of a person with mpox without having been disinfected or laundered<sup>Δ</sup></li> </ul> </li> </ul> <p class="extra_spacing"><strong>or</strong></p> <ul> <li>Contact between an exposed individual's clothing with either:<sup>¥</sup> <ul> <li>The person with mpox's skin lesions or bodily fluids</li> <li>The person with mpox's soiled linens or dressings</li> </ul> </li> </ul> </td> <td> <ul> <li>Being within 6 feet for a total of 3 hours or more (cumulative) of an unmasked patient with mpox without wearing a surgical mask or respirator</li> </ul> <p class="extra_spacing"><strong>or</strong></p> <ul> <li>Unprotected contact between an exposed individual's intact skin and the skin lesions or bodily fluids from a patient with mpox or soiled materials (eg, linens, clothing)</li> </ul> <p class="extra_spacing"><strong>or</strong></p> <ul> <li>Activities resulting in contact between an exposed HCP's clothing and the patient's skin lesions or bodily fluids or their soiled materials while not wearing a gown<sup>¥</sup></li> </ul> </td> <td> <p>Post-exposure vaccination determined on a case-by-case basis<sup>◊</sup><sup>‡</sup></p> Monitor for 21 days</td> </tr> <tr class="highlight_gray_text"> <td><strong>Lower</strong></td> <td> <ul> <li>Entry into the living space of a person with mpox (regardless of whether the person with mpox is present) and in the absence of any exposures above</li> </ul> </td> <td> <ul> <li>Entry into the contaminated room or patient care area of a patient with mpox without wearing all recommended PPE and in the absence of any exposures above<sup>†</sup></li> </ul> </td> <td>Monitor for 21 days</td> </tr> <tr> <td><strong>No risk</strong></td> <td> <ul> <li>No contact with the person with mpox, their potentially infectious contaminated materials, or entry into their living space</li> </ul> </td> <td> <ul> <li>No contact with the patient with mpox or their contaminated materials</li> <li>No entry into the contaminated patient room or care area</li> </ul> </td> <td> </td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>This table is to be used in conjunction with UpToDate content on mpox, orthopoxvirus vaccines, and infection prevention. It provides a framework for determining risk after an exposure; however, institutional policies may vary.</p>
In November 2022, the World Health Organization changed the name of the disease referred to as "monkeypox" to "mpox." The virus that causes mpox continues to be referred to as monkeypox virus.</div><div class="graphic_footnotes"><p>HCP: health care personnel; PPE: personal protection equipment.</p>
<p>* During the 2022 global outbreak, post-exposure vaccination is not indicated for those who received pre-exposure prophylaxis and those who already developed mpox during the outbreak. In addition, if mpox develops after the first vaccine dose, the second dose should be deferred.</p>
<p>¶ This includes activities such as sharing food or handling or sharing of linens used by a person with mpox.</p>
<p>Δ For appropriate disinfection, individuals should use a disinfectant registered with the US Environmental Protection Agency (EPA) with an emerging <a href="https://www.epa.gov/pesticide-registration/disinfectants-emerging-viral-pathogens-evps-list-q" target="_blank">viral pathogens claim</a>.</p>
<p>◊ Post-exposure prophylaxis generally refers to vaccination with the modified Ankara vaccina (MVA) vaccine (sold as JYNNEOS in the United States), which requires two doses 28 days apart. A replication-competent vaccine (ACAM2000) can also be considered for post-exposure prophylaxis in select patients but can be associated with severe adverse reactions.</p>
<p>§ Vaccination in this setting is referred to as expanded post-exposure prophylaxis (PEP) or PEP++. Eligibility is typically dictated by local public health authorities and depends in part on the availability of vaccine. Some jurisdictions have expanded eligibility beyond the risk groups listed in the table. For example, in Philadelphia, sex workers, regardless of gender, are eligible to receive vaccination.</p>
<p>¥ This type of contact may occur during turning, bathing, or assisting with transfer.</p>
<p>‡ The decision to vaccinate depends on the specific details of the exposure as well as the exposed individual's risk of developing severe disease.</p>
† The authors consider HCP who use appropriate PPE and follow recommended infection control precautions to have no recognized exposure, and for this population we do not recommend monitoring. Appropriate PPE includes use of a gown, gloves, eye protection (goggles or face shield), and a National Institute for Occupational Safety and Health (NIOSH)-approved N95 filtering facepiece or equivalent or higher-level respirator. While there is no epidemiologic evidence to date that monkeypox virus is spread by the airborne route, at this time the CDC recommends respiratory protection be used.</div><div class="graphic_reference">Adapted from:
<ol>
<li>Monitoring and Risk Assessment for Persons Exposed in the Community. United States Centers for Disease Control and Prevention. Available at: <a href="https://www.cdc.gov/poxvirus/monkeypox/clinicians/monitoring.html" target="_blank">https://www.cdc.gov/poxvirus/monkeypox/clinicians/monitoring.html</a> (Accessed on August 23, 2022).</li>
<li>Infection Prevention and Control of Monkeypox in Healthcare Settings. United States Centers for Disease Control and Prevention. Available at: <a href="https://www.cdc.gov/poxvirus/monkeypox/clinicians/infection-control-healthcare.html" target="_blank">https://www.cdc.gov/poxvirus/monkeypox/clinicians/infection-control-healthcare.html</a> (Accessed on August 23, 2022).</li>
<li>Monkeypox: Vaccination Strategies. United States Centers for Disease Control and Prevention. Available at: <a href="https://www.cdc.gov/poxvirus/monkeypox/interim-considerations/overview.html#anchor_1660077319531" target="_blank">https://www.cdc.gov/poxvirus/monkeypox/interim-considerations/overview.html#anchor_1660077319531</a> (Accessed on August 23, 2022).</li>
</ol></div><div id="graphicVersion">Graphic 139449 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
